fbpx
June 23, 2022

Promising New Tool for Better Migraine Management in Primary Care Promising New Tool for Better Migraine Management in Primary Care

A new tool can help streamline diagnosis and treatment of migraine in the primary care setting, new research suggests. Early results from a small pilot study […]
June 23, 2022

Top Medications Most Often Linked to Headache Top Medications Most Often Linked to Headache

DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in […]
June 23, 2022

Stroke Study Reveals a High Frequency of Mendelian Disorders Stroke Study Reveals a High Frequency of Mendelian Disorders

The study covered in this summary was published in medrxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Exome sequencing (ES) is […]
June 23, 2022

Sleep Tied to Objective and Subjective Cognition Sleep Tied to Objective and Subjective Cognition

Amy Costa Poor objective sleep efficiency may contribute to older adults overestimating their cognitive abilities, preliminary findings from a pilot study of objective and subjective cognitive […]
June 23, 2022

Recommended Drugs for Headache Rarely Prescribed in EDs Recommended Drugs for Headache Rarely Prescribed in EDs

DENVER – In line with recommendations, emergency departments dramatically reduced their use of opioids as treatments for headache over a recent 11-year period, a new study […]
June 23, 2022

More Positive Phase 3 Results ‘Raise the Bar’ for Migraine Drug More Positive Phase 3 Results ‘Raise the Bar’ for Migraine Drug

Atogepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist approved last year for migraine, is superior to placebo not only in terms of a 50% or […]
June 22, 2022

Acupuncture Deep Needling Points to Greater Headache Relief Acupuncture Deep Needling Points to Greater Headache Relief

Acupuncture deep needling provides significant, long-term relief from chronic tension type headache (TTH), new research suggests. Result of a randomized trial showed that though the majority […]
June 22, 2022

Novel Drug for Relapsing-Remitting MS: New Phase 2 Data Novel Drug for Relapsing-Remitting MS: New Phase 2 Data

The novel drug vidofludimus calcium (Immunic Therapeutics) is safe and effective for patients with relapsing-remitting multiple sclerosis (RRMS), new research suggests. Vidofludimus calcium is an investigational […]
June 22, 2022

Vulnerable Brain Networks Predict Alzheimer’s Disease Vulnerable Brain Networks Predict Alzheimer’s Disease

The study covered in this summary was published on bioRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaway Identification of network-based biomarkers […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0